Navigation Links
Global miRNA Market Outlook to 2018
Date:12/24/2013

NEW YORK, Dec. 24, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Global miRNA Market Outlook to 2018

http://www.reportlinker.com/p01929534/Global-miRNA-Market-Outlook-to-2018.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology

The recent discovery of miRNA and its wide applicability have sparked off a lot of interest among researchers as well as commercial players. Owing to the same, there are numerous clinical trials being organized all over the world in order to assess the potential of miRNA in diverse fields such as Cancer, Asthma, Heart disorders, Diabetes, Hepatitis etc. The report, "Global miRNA Market Outlook to 2018" provides an in-depth analysis of the various aspects of miRNA at the industry as well as the research front.

The market has been divided into three sections i.e., The Americas, Europe and Asia Pacific. These regions have then been analyzed to draw patterns in terms of research areas and applicability. A brief look at the market suggests that cancer is the most researched topic and regions such as United States, United Kingdom, France, Israel and China are the major players interested in evaluating the role played by miRNA.

Most of the current research is focused on utilizing miRNA for diagnostic purposes such as expression profiling, response evaluation and setting potential biomarkers in diseases. Another application is in the field of therapeutics where miRNA mimics and inhibitors are being applied to control gene translation and consequently its expression.

After an exhaustive study of the industry, RNCOS has laid out the primary market players. These players are working over a vast variety of products such as miRNA extraction and purification kits, and miRNA mimics and inhibitors. There are other players who are solely providing miRNA associated diagnostic services and assessing their therapeutic potential.

Overall, even though the market is in its nascent stage at the moment, it is expanding at an almost exponential rate. With new players entering the market, increase in the number of collaborations and strong support from research institutes, the miRNA market is bound to witness rampant diversification and growth in the coming years.

1. Analyst View

2. Research Methodology

3. miRNA - An Introduction

4. miRNA Techniques

4.1 miRNA Purification

4.2 miRNA Labeling

4.3 miRNA Linear Amplification

4.4 miRNA Microarrays

4.5 miRNA qRT-PCR

4.6 miRNA Inhibition

5. Global miRNA Market Outlook to 2018

5.1 By Geography

5.1.1 The Americas

5.1.2 Europe

5.1.3 Asia Pacific (APAC)

6. Ongoing miRNA Research by Disease

6.1 Cancer

6.2 Cardiovascular Diseases

6.3 Metabolic Diseases

6.4 Asthma

6.5 Hepatitis

7. Key Players

7.1 Mirna Therapeutics, Inc.

7.2 Rosetta Genomics, Ltd.

7.3 InteRNA Technologies B.V.

7.4 Santaris Pharma A/S

7.5 Regulus Therapeutics

7.6 miRagen Therapeutics

7.7 Qiagen

7.8 Sigma-Aldrich Corporation

7.9 Thermo Fisher Scientific Inc.

7.10 Agilent Technologies Inc.

7.11 Life Technologies Corporation

7.12 System Biosciences

7.13 GeneCopoeia

 

List of Figures:

Figure 3-1: miRNA Biogenesis

Figure 5-1: Global - miRNA Market (Million US$), 2012-2018

Figure 5-2: Ongoing miRNA Research by Geography (%), 2013

Figure 5-3: The Americas - miRNA Market (Million US$), 2012-2018

Figure 5-4: The Americas - Ongoing miRNA Research by Disease (%), 2013

Figure 5-5: Europe - miRNA Market (Million US$), 2012-2018

Figure 5-6: Europe - Ongoing miRNA Research by Disease (%), 2013

Figure 5-7: Europe - Ongoing miRNA Research by Country (%), 2013

Figure 5-8: APAC - miRNA Market (Million US$), 2012-2018

Figure 5-9: APAC - Ongoing miRNA Research by Disease (%), 2013

Figure 5-10: APAC - Ongoing miRNA Research by Country (%), 2013

Figure 6-1: Ongoing miRNA Research by Disease (%), 2013

Figure 6-2: Cancer - Ongoing miRNA Research (%), 2013

 

List of Tables:

Table 4-1: miRNA Purification Products by Supplier

Table 4-2: miRNA Labeling Products by Supplier

Table 4-3: miRNA Linear Amplification Products by Supplier

Table 4-4: miRNA Microarray Products by Supplier

Table 4-5: miRNA qRT-PCR Products by Supplier

Table 4-6: miRNA Inhibition Products by Supplier

Table 5-1: The Americas - Ongoing miRNA Research (2013)

Table 5-2: Europe - Ongoing miRNA Research (2013)

Table 5-3: APAC - Ongoing miRNA Research (2013)

Table 6-1: miRNAs associated with Cancer

Table 6-2: miRNA associated with Cardiovascular Diseases

Table 6-3: miRNAs associated with Metabolic Disorders

Table 6-4: miRNAs associated with Hepatitis

Table 7-1: Mirna Therapeutics - miRNA Research Pipeline

Table 7-2: Rosetta Genomics - miRNA based Cancer Tests

Table 7-3: InteRNA - miRNA Research Pipeline

Table 7-4: Santaris Pharma - miRNA Research Pipeline

Table 7-5: Regulus Therapeutics - miRNA Research Pipeline

Table 7-6: miRagen - miRNA Research Pipeline

Table 7-7: Qiagen - miRNA Associated Product Line

Table 7-8: Sigma Aldrich - miRNA Associated Product Line

Table 7-9: Thermo Fisher - miRNA Associated Product Line

Table 7-10: Agilent - miRNA Associated Product Line

Table 7-11: Life Technology - miRNA Associated Product Line

Table 7-12: System Biosciences - miRNA Associated Product Line

Table 7-13: GeneCopoeia - miRNA Associated Product Line

 

To order this report: Global miRNA Market Outlook to 2018

http://www.reportlinker.com/p01929534/Global-miRNA-Market-Outlook-to-2018.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology

Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001


'/>"/>
SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. MedImmune Announces Winners of Its 6th Annual Global Abstract Competition
2. MarketsandMarkets: Global Prostate Cancer Therapeutics Market worth $6,457 Million by 2020
3. Global Cleantech Cluster Association Names New York City Startup Rentricity to Global Top 10 List
4. StemCyte Adds World Class Talent to its North America and Global Operations
5. Sequenom Named to NASDAQ Global Select Market
6. Synthetic Biology: Emerging Global Markets
7. MacroGenics Receives Milestone Payment as Part of Its Global DARTâ„¢ Alliance with Boehringer Ingelheim
8. Amgen to Present at the 30th Annual J.P. Morgan Global Healthcare Conference
9. Hemodialysis Machine Industry 2012 Global & China Market Research Report - ReportsnReports
10. MarketsandMarkets: Global Seed Treatment Market worth $3430.3 Million by 2016
11. Accuray Surpasses 600 Installations Globally
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... Inc. (NASDAQ: NBIX ) today announced its financial results for ... --> --> For the fourth quarter of ... $0.34 loss per share, compared to a net loss of $19.4 ... 2014. For the year ended December 31, 2015, the Company reported ... as compared to a net loss of $60.5 million, or $0.81 ...
(Date:2/11/2016)... , Feb. 11, 2016  Wellcentive today announced ... Portland, Oregon -based community care organization ... population health analytics, quality reporting and care management ... strengthen its team of quality managers, analysts and ... the provider groups serving FamilyCare members. ...
(Date:2/11/2016)... ... February 11, 2016 , ... ... 150 years, continues today to pursue the highest level of accuracy and quality ... the AR9 Refractometer and the AR5 Refractometer. Accurate, reliable and tough enough ...
(Date:2/10/2016)... Md. , Feb. 10, 2016  The Maryland ... Busch , has announced that University of Maryland School ... PhD, MBA and University of Maryland Medical System President ... of the "Speaker,s Medallion," the highest honor given to ... of Delegates. Dean Reece and Mr. ...
Breaking Biology Technology:
(Date:2/2/2016)... Technology Enhancements Accelerate Growth of X-ray Imaging ... and computed radiography markets in Thailand ... Indonesia (TIM). It provides an in-depth analysis ... as regional market drivers and restraints. The study offers ... market attractiveness, both for digital and computed radiography. Market ...
(Date:2/1/2016)... Feb. 1, 2016  Today, the first day of ... plans to develop a first of its kind workplace ... IBM Watson. In the first application of ... IBM ), and Welltok will create a new ... with cognitive analytics, delivered on Welltok,s health optimization platform. ...
(Date:1/25/2016)... Unisys Corporation (NYSE: UIS ) today announced the implementation ... New York City , to help U.S. ... the United States using passports that are ... of the system at Dulles last year. The system will ... 2016. --> pilot testing of the system at ...
Breaking Biology News(10 mins):